These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16551496)

  • 1. In vitro antimicrobial activity of liposomal meropenem against Pseudomonas aeruginosa strains.
    Drulis-Kawa Z; Gubernator J; Dorotkiewicz-Jach A; Doroszkiewicz W; Kozubek A
    Int J Pharm; 2006 Jun; 315(1-2):59-66. PubMed ID: 16551496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
    Alipour M; Halwani M; Omri A; Suntres ZE
    Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study.
    Rukholm G; Mugabe C; Azghani AO; Omri A
    Int J Antimicrob Agents; 2006 Mar; 27(3):247-52. PubMed ID: 16472992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Mugabe C; Azghani AO; Omri A
    J Antimicrob Chemother; 2005 Feb; 55(2):269-71. PubMed ID: 15590716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and study of antimicrobial activity of nanoliposomal meropenem against Pseudomonas aeruginosa isolates.
    Zahra MJ; Hamed H; Mohammad RY; Nosratollah Z; Akbarzadeh A; Morteza M
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):975-980. PubMed ID: 27322561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between Pseudomonas aeruginosa cells and cationic PC:Chol:DOTAP liposomal vesicles versus outer-membrane structure and envelope properties of bacterial cell.
    Drulis-Kawa Z; Dorotkiewicz-Jach A; Gubernator J; Gula G; Bocer T; Doroszkiewicz W
    Int J Pharm; 2009 Feb; 367(1-2):211-9. PubMed ID: 18952159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains.
    Drenjancević D; Vranes J; Bedenić B; Sakić-Zdravcević K
    Coll Antropol; 2007 Mar; 31(1):221-5. PubMed ID: 17598405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Solak S; Willke A; Ergönül O; Tekeli E
    Int J Antimicrob Agents; 2005 Feb; 25(2):181-2. PubMed ID: 15664492
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the in vitro antimicrobial activity of liposomes containing meropenem and gentamicin.
    Drulis-Kawa Z; Gubernator J; Dorotkiewicz-Jach A; Doroszkiewicz W; Kozubek A
    Cell Mol Biol Lett; 2006; 11(3):360-75. PubMed ID: 16847556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
    Gad GF; El-Domany RA; Zaki S; Ashour HM
    J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing resistance evolution in Pseudomonas aeruginosa using pharmacodynamic modelling: application to meropenem dosage and combination therapy.
    Santos Filho L; Eagye KJ; Kuti JL; Nicolau DP
    Clin Microbiol Infect; 2007 Jun; 13(6):579-85. PubMed ID: 17331121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.
    Mugabe C; Halwani M; Azghani AO; Lafrenie RM; Omri A
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2016-22. PubMed ID: 16723560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin.
    Halwani M; Blomme S; Suntres ZE; Alipour M; Azghani AO; Kumar A; Omri A
    Int J Pharm; 2008 Jun; 358(1-2):278-84. PubMed ID: 18448284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome-encapsulated antibiotics: preparation, drug release and antimicrobial activity against Pseudomonas aeruginosa.
    Lagacé J; Dubreuil M; Montplaisir S
    J Microencapsul; 1991; 8(1):53-61. PubMed ID: 1908898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
    Halwani M; Yebio B; Suntres ZE; Alipour M; Azghani AO; Omri A
    J Antimicrob Chemother; 2008 Dec; 62(6):1291-7. PubMed ID: 18931388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of imipenem resistance among Pseudomonas aeruginosa isolates from a Polish paediatric hospital (1993-2002).
    Patzer JA; Dzierzanowska D
    Int J Antimicrob Agents; 2007 Feb; 29(2):153-8. PubMed ID: 17157481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
    Ludwig E; Konkoly-Thege M; Kuti JL; Nicolau DP
    Int J Antimicrob Agents; 2006 Nov; 28(5):433-8. PubMed ID: 17046212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.